{"nct_id":"NCT01266954","title":"An Open Label Study To Investigate the Pharmacokinetics and Pharmacodynamics of Repeat Escalating Doses of the Oral AKT Inhibitor GSK2141795 by 18F FDG PET Analysis in Subjects With Ovarian Cancer","status":"COMPLETED","status_verified_date":"2017-11","start_date":"2010-06-01","start_date_type":"ACTUAL","primary_completion_date":"2011-09-01","primary_completion_date_type":"ACTUAL","completion_date":"2011-09-01","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}